Fact sheet on lopinavir and ritonavir (LPV/R) oral pellets: 40 mg/10 mg per capsule bottle pack cointaining 120 capsules
View StatisticsShow Statistical Information
World Health Organization, Interagency Task Team (IATT) on Prevention of HIV Infection in Pregnant Women, Mothers and their Children & UNICEF. (2015). Fact sheet on lopinavir and ritonavir (LPV/R) oral pellets: 40 mg/10 mg per capsule bottle pack cointaining 120 capsules. WHO/IATT/UNICEF. http://www.who.int/iris/handle/10665/193543
MetadataShow full item record
Showing items related by title and MeSH subject.
Policy brief: supply planning for new dosage form of lopinavir and ritonavir oral pellets: 40 mg/10 mg per capsule, pack of 120 capsules World Health Organization; Interagency Task Team (IATT) on Prevention of HIV Infection in Pregnant Women, Mothers and their Children; UNICEF (2015)
El Sayed, A.; Boraie, N.A.; Ismail, F.A.; El Khordagui, L.K.; Khalil, S.A. (2007)The pharmaceutical quality of 7 local omeprazole capsule brands in Egypt was assessed relative to the proprietary product [Losec[R]]. Drug content, content uniformity, drug release [using USP test for enteric coated articles and a modified release test] were determined. Products were subjected to a 3-month stability study. Of the 7 brands, 6 had satisfactory drug content and content uniformity. All brands passed the USP drug release test. The modified release test proved to be more discriminative. After 3 months storage, drug content of 3 brands ...